We are (Diacetoxyiodo)benzene CAS:3240-34-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  (Diacetoxyiodo)benzene
CAS.NO:   3240-34-4
Iodosobenzene diacetate
bis-acetoxy iodobenzene
Phenyliodo diacetate
iodosobensene I,I-diacetate
Iodobenzene diacetate
Iodine, bis(acetyloxy)phenyl-
phenyliodonium diacetate
Phenyliodine diacetate
iodobenzene 1,1-diacetate

Molecular Formula:  C10H11IO4
Molecular Weight: 322.09600

Physical and Chemical Properties:
Density: 1.686g/cm3
Boiling point: 456.8ºC at 760 mmHg
Melting point: 161-163 °C(lit.)
Flash point: 230.1ºC
Refractive index:/

Appearance:  white to light yellow crystal powder
Loss on drying:≤0.5%

 25kg  cardboard drum or according to customer specified requirements
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
(Diacetoxyiodo)benzene is a hypervalent iodine reagent that is used in conjunction with catalytic amount of sodium azide in acetonitrile, which enables oxidative decarboxylation of 2-aryl carboxylic acid into the corresponding aldehydes, ketones and nitriles.Intermediates of Irinotecan CAS:97682-44-5.


Related News: In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of “predictable” clinical value for life-threatening diseases for which effective treatment is not immediately available.82732-07-8 The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.m-cresol CAS:108-39-4 Under the sub-licensing agreement, Mankind will market the drug under its own trademark while Glenmark will manufacture and supply it to the drug firm.4-Methylthiazole-5-carboxaldehyde Beta Bionics is a for-profit Massachusetts public benefit corporation founded in 2015 to commercialize the iLet, a revolutionary bionic pancreas that is driven by mathematical dosing algorithms, which incorporate lifelong autonomous learning to automatically control glycemia.Therefore, the R & D capabilities and registration capabilities of API companies have become the core factors of competition.

Related Products
Product Name
1-bromodibenzo[b,d]furan View Details
N-Cbz-glycine Ethyl Ester View Details
2-Bromo-4-fluorophenol View Details
5-Bromopyridine-2-carboxylic acid manufacturer Substance P manufacturer 2,3-Dihydrobenzo[b]furan-5-carbaldehyde manufacturer (S)-((2-Guanidino-4-thiazolyl)methylisothiourea dihydrochloride manufacturer Antioxidant DPP manufacturer